Telix Pharmaceuticals' quarterly report shows a strong revenue contribution from its acquired nuclear medicine business RLS Radiopharmacies.

Goodman Group is increasing its presence in the global data centres market, nabbing a Microsoft executive to lead its ...

The ASX has opened higher on April 23, 2025, as US President Donald Trump said he won't "play hardball" with China in trade negotiations.

Queensland developer QMines (ASX:QML) is looking to add the Mount Mackenzie gold and silver project to its portfolio.

The uranium market has been described as "broken", but there's reason to think a price rebound is inevitable. These stocks are getting ready.

In a difficult climate for capital raisings, biotechs are turning to loans backed by their expected research and development tax refunds.

Big pharma’s jumped into CBD sleep land with Sandoz backing Avecho; could this bring a new rush into ASX CBD stocks like Neurotech?

Tariffs set by US President Donald Trump have upset the global economy but Pure Hydrogen believes it can leverage them to its ...